SC 13G

CELLDEX THERAPEUTICS INC.

Company: Celldex Therapeutics, Inc.
Filed: May 26, 2011
Accession Number: 0000902664-11-001023

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →

View Document ↗ View on SEC.gov ↗